"The current climate is sunny when it comes to securing capital for diagnostics entrepreneurs and start-up companies. The industry is fast becoming a foremost area of interest for health-care investors and has experienced an unprecedented number of mergers and acquisitions in recent years, as well as successful public offerings. This panel will discuss how advances in diagnostics technologies are yielding higher margins, reduced risk and more timely return on investment— and changing the historical bias among health-care investors against diagnostic companies."

Objective1:Articulate the major business advantages that are attracting investors to diagnostics.

Objective2: Examine the trends toward consolidation and comprehensive diagnostic product portfolios.

Objective3:Offer advice from venture capitalists on how to sell your company's diagnostics value proposition.